02 December 2024

SOLASTA Bio raises $14m, plans to commercialize peptide-based biopesticides in ‘half the time’ it takes for synthetics

UK-based ag biotech startup SOLASTA Bio has closed a $14 million oversubscribed Series A round, bringing its total funding to $19 million

SOLASTA Bio raises $14m for peptide-based biopesticides: SOLASTA Bio raises $14m, plans to commercialize peptide-based biopesticides in ‘half the time’ it takes for synthetics

More articles

18 June 2026

SOLASTA® Bio at World Agri‑Tech 2026 | Advancing the future of sustainable insect control

In March, SOLASTA Bio participated in the World Agritech Innovation Summit in San Francisco which included SOLASTA’s exhibition booth and presentations. We were proud to share our latest progress on ...

Read more

16 January 2026

SOLASTA Bio placed in ‘Ones to Watch’ feature of the The Sunday Times 100 Tech, Britain’s fastest-growing private technology companies

Read more

See more